Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

US Patent 12090147 · Granted Sep 17, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
Methods and combinations for treatment and T cell modulation2025
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)2024
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)2024
Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((22024
Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((22024
Methods of assessing suitability of use of pharmaceutical compositions of albumi2024
Antiproliferative compounds and bispecific antibody against BCMA and CD3 for com2024
Antiproliferative compounds and methods of use thereof2024
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)2023
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)2023